Altre lingue Oramed Pharmaceuticals Inc.

Azioni

ORMP

US68403P2039

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 21/06/2024			Variaz. 5gg	Var. 1 gen.
2,3 ^USD	+4,07%		+2,22%	-0,43%

12/06	Scilex Holding firma una lettera di impegno per un finanziamento di 100 milioni di dollari; le azioni avanzano prima del mercato	MT
10/06	Oramed Pharmaceuticals Inc. nomina Avraham Gabay come Tesoriere e Segretario, con effetto dal 18 giugno 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

ORAMED PHARMACEUTICALS : 2023 ANNUAL REPORT	20/06
Oramed Pharmaceuticals : PROXY STATEMENT OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 1, 2024	20/06
Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket	12/06
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024	10/06
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Treasurer and Secretary, Effective as of June 18, 2024	10/06
Compugen Names David Silberman CFO	15/05
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024	13/05
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024	13/05
Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K	13/05
Oramed: Q1 Earnings Snapshot	10/05
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	06/05
Oramed Pharmaceuticals : 13D-Nadav Kidron	26/03
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19/03
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19/01
Oramed Pharmaceuticals : Other Report or Announcement	02/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Oramed Pharmaceuticals Inc.

Azioni

ORMP

US68403P2039

Altre lingue

Filtri